Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy

查看全文 作　　者：Carlos A [1,2]Castaneda;Elizabeth [3]Mittendorf;Sandro [4]Casavilca;Yun [5]Wu;Miluska [1]Castillo;Patricia [1,4]Arboleda;Teresa [4]Nunez;Henry [4]Guerra;Carlos [4]Barrionuevo;Ketty Dolores-[1]Cerna;Carolina Belmar-[1]Lopez;Julio [6]Abugattas;Gabriela [6]Calderon;Miguel De La [6]Cruz;Manuel [6]Cotrina;Jorge [6]Dunstan;Henry L [2]Gomez;Tatiana [2]Vidaurre

机构地区：[1]Department of Research, Instituto Nacional de Enfermedades Neoplasicas;[2]Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplasicas;[3]Department of Surgical Oncology, the University of Texas MD Anderson Cancer Center;[4]Department of Pathology, Instituto Nacional de Enfermedades Neoplasicas;[5]Department of Pathology, Division of Pathology, the University of Texas MD Anderson Cancer Center;[6]Department of Breast Cancer Surgery, Instituto Nacional de Enfermedades Neoplasicas

出　　处：《World Journal of Clinical Oncology》索引2016年第7卷第5期,共8页

摘　　要：AIM To determine influence of neoadjuvant-chemotherapy(NAC) over tumor-infiltrating-lymphocytes(TIL) intriple-negative-breast-cancer(TNBC).METHODS TILs were evaluated in 98 TNBC cases who came to Instituto Nacional de Enfermedades Neoplasicas from 2005 to 2010. Immunohistochemistry staining for CD3, CD4, CD8 and FOXP3 was performed in tissue microarrays(TMA) sections. Evaluation of H/E in full-face and immunohistochemistry in TMA sections was performed in pre and post-NAC samples. STATA software was used and P value < 0.05 was considered statistically significant. RESULTS Higher TIL evaluated in full-face sections from pre-NAC tumors was associated to pathologic-complete-response(pCR)(P = 0.0251) and outcome(P = 0.0334). TIL evaluated in TMA sections showed low level of agreement with full-face sections(ICC = 0.017-0.20) and was not associated to pCR or outcome. TIL in post-NAC samples were not associated to response or outcome. PostNAC lesions with pC R had similar TIL levels than those without pCR(P = 0.6331). NAC produced a TIL decrease in full-face sections(P < 0.0001). Percentage of TIL subpopulations was correlated with their absolute counts. Higher counts of CD3, CD4, CD8 and FOXP3 in pre-NAC samples had longer disease-free-survival(DFS). Higher counts of CD3 in pre-NAC samples had longer overallsurvival. Higher ratio of CD8/CD4 counts in pre-NAC was associated with pCR. Higher ratio of CD4/FOXP3 counts in pre-NAC was associated with longer DFS. Higher counts of CD4 in post-NAC samples were associated with pCR.CONCLUSION TIL in pre-NAC full-face sections in TNBC are correlated to longer survival. TIL in full-face differ from TMA sections, absolute count and percentage analysis of TIL subpopulation closely related. 关键词：TRIPLE-NEGATIVE BREAST cancer SURVIVAL Tumor-infiltrating LYMPHOCYTES NEOADJUVANT therapy

相关文献

参考文献（24）
引证文献（6）
耦合文献（0）

参考文献(24)

引证文献(6)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy

参考文献(24)

引证文献(6)

用户提示